Mersana Therapeutics, Inc. (MRSN) Social Stream



Mersana Therapeutics, Inc. (MRSN): $2.27

0.25 (-9.92%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add MRSN to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#244 of 333

in industry

MERSANA THERAPEUTICS INC (MRSN) Price Targets From Analysts

Use the tables below to see what analysts covering MERSANA THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 7 $32 $12 $25 $3.23 673.99%
2021-11-12 7 $32 $11 $24.833 $3.23 668.82%
2022-01-07 7 $32 $11 $23.833 $3.23 637.86%
2022-02-04 7 $32 $11 $24 $3.23 643.03%
2022-02-17 7 $32 $11 $22.5 $3.23 596.59%
2022-03-01 7 $32 $11 $21.5 $3.23 565.63%
2022-03-21 6 $32 $10 $19.6 $3.23 506.81%
2022-05-09 6 $32 $10 $17.8 $3.23 451.08%
2022-05-10 6 $32 $13 $19.25 $3.23 495.98%
2022-08-09 5 $20 $14 $16.666 $3.23 415.98%
2022-11-07 5 $20 $14 $17 $3.23 426.32%
2022-11-21 6 $20 $12 $15.75 $3.23 387.62%
2023-02-28 7 $20 $12 $14.8 $3.23 358.2%
2023-03-01 7 $20 $12 $15 $3.23 364.4%
2023-03-19 7 $20 $10 $14.285 $3.23 342.26%
2023-05-09 7 $20 $10 $14.571 $3.23 351.11%
2023-05-11 7 $20 $10 $15 $3.23 364.4%
2023-06-16 8 $20 $5 $12.875 $3.23 298.61%
2023-07-27 8 $15 $2 $9.25 $3.23 186.38%
2023-07-28 9 $15 $1 $8.5 $3.23 163.16%
2023-08-08 9 $15 $1 $7.375 $3.23 128.33%
2023-11-07 9 $14 $1 $5.333 $3.23 65.11%
2023-12-04 9 $14 $1 $6 $3.23 85.76%

The Trend in the Analyst Price Target


MRSN's average price target has moved down $23.8 over the prior 34 months.

Over the past 45 weeks, MRSN's average upside potential has been 282.19%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-02-28 7 20 12 15.000 6.06 147.52%
2023-06-16 8 15 5 10.500 3.47 202.59%
2023-06-16 8 20 10 13.625 3.47 292.65%
2023-07-28 9 15 1 7.375 1.26 485.32%
2023-12-04 9 14 1 6.000 2.04 194.12%

MRSN Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.56 3 0 5 1 1 9

The Trend in the Broker Recommendations


Over the past 31 weeks, MRSN's average broker recommendation rating worsened by 1.56.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • To contextualize these metrics, consider that out of all US stocks, MERSANA THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 3003.71% of them.
  • To contextualize these metrics, consider that out of all US stocks, MERSANA THERAPEUTICS INC's variance in analysts' estimates is lower than -2622.14% of them.
  • In the context of all US stocks, MERSANA THERAPEUTICS INC's average analyst price target is higher than 650.4% of them.
  • In the context of stocks in the small market cap category, MERSANA THERAPEUTICS INC's number of analysts covering the stock is higher than 2649.33% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to MERSANA THERAPEUTICS INC are MTNB, ORMP, and FBRX.

Is MRSN a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!